相关实验视频
Updated: Jan 6, 2026

08:06
Mixed Reality Assisted Radical Endoscopic Thyroidectomy
Published on: January 31, 2025
628
格雷夫斯病管理的最新进展:最新情况
Shailendra Kumar Singh1, Rina Singh1, Arun Kumar Pandey2
1Department of Endocrine, Endocrine Clinic, Gilat Bazar, Varanasi, Uttar Pradesh, 221002, India.
Postgraduate medical journal
|November 19, 2025
概括
格雷夫斯病 (GD) 治疗面临着当前的抗甲状腺药物 (ATD) 和放射性治疗 (RIT) 等疗法所面临的挑战. 新型免疫疗法具有前景,但需要进一步开发以解决有效性和安全性问题.
科学领域:
- 内分泌学 在内分泌学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 格雷夫斯病 (GD) 的治疗是复杂的,常规疗法如抗甲状腺药物 (ATD),手术和放射性治疗 (RIT) 有显著的局限性.
- 甲状腺功能障碍与高复发率和副作用有关,而确定的治疗可以导致永久性甲状腺功能低下症并增加格雷夫斯眼科病的风险.
研究的目的:
- 审查当前格雷夫斯病治疗方法的局限性.
- 探索针对特定免疫路径的新型免疫疗法的潜力.
主要方法:
- 关于传统和新兴的格雷夫氏病疗法的文献综述.
- 对新型免疫调节药物的机制,疗效和安全性分析.
主要成果:
- 目前GD治疗 (ATD,手术,RIT) 有显著的缺点,包括复发,副作用和长期并发症.
- 新兴的免疫疗法选择性调节免疫系统,但可能会带来诸如增加感染率和可变有效性等风险.
结论:
- 新型免疫疗法为格雷夫斯病提供了有针对性的治疗方法,但需要进一步研究以优化疗效和安全性.
- 持续开发新的治疗药物对于改善GD管理和实现更好的患者结果至关重要.
相关概念视频
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K
Urinary Tract Calculi III: Medical Management
169
The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
169
Diabetes: Management and Pharmacotherapy
835
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
835
Inflammatory Bowel Disease IV: Pharmacological Management
427
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
427
Chronic Kidney Disease III: Interprofessional Care
316
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
316
Chronic Kidney Disease IV: Nursing Management
283
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
283
